Specifications
Neostigmine Methyl Sulfate 0.5 mg/mL Injectable Solution
Indications
Reverse the effects of non-depolarizing neuromuscular blocking agents (for example: Tubocurarine, Pancuronium, etc.); prophylaxis and treatment of postoperative intestinal atony and urinary retention; treatment of myasthenia gravis during acute exacerbations, when the condition is severe or in neonates.
Presentations
Box x 10 Ampoules x 1 mL
Box * 100 Ampoules * 1 mL
Box * 50 Ampoules * 1 mL
Composition
Each mL contains: Neostigmine methyl sulfate 0.50 mg.
Dosage
According to medical prescription.
Sales method
Under medical prescription.